Abingworth works alongside entrepreneurs to develop their ideas into products that have an impact on health. Within this market, the Company participates in a wide range of opportunities spanning therapeutics, medical devices, diagnostics, instrumentation, and software. Abingworth invests in seed stage projects, technology platforms, preclinical and clinical assets as well as approved and marketed products. Supporting private and public companies, Abingworth aims to partner with the most innovative entrepreneurs to address significant unmet needs in healthcare.

 

Type
Investor
HQ
London, GB
Founded
1973
Size (employees)
27 (est)
Abingworth was founded in 1973 and is headquartered in London, GB
Report incorrect company information

Key People/Management at Abingworth

Tim Haines

Tim Haines

Managing Partner
Kurt von Emster

Kurt von Emster

Managing Partner
Stephen Bunting

Stephen Bunting

Chairman
James Abell

James Abell

Partner & CFO
Vincent Miles

Vincent Miles

Partner
Shelley Chu

Shelley Chu

Partner
Show more

Abingworth Office Locations

Abingworth has offices in Boston, Menlo Park and London
London, GB (HQ)
38 Jermyn St
Boston, US
501 420 Boylston St
Menlo Park, US
3000 Sand Hill Rd
Show all (3)
Report incorrect company information

Abingworth News and Updates

NousCom wraps up Series B round

NousCom, a Swiss oncology company, has closed its Series B funding round at 42 million euros. Abingworth was the lead investor. Also, 5AM Ventures, LSP and Versant Ventures participated in the round.
Report incorrect company information